Abbott India

Market Cap: Mid Cap
Industry: Pharmaceuticals & Biotechnology
ISIN: INE358A01014
NSEID: ABBOTINDIA
BSEID: 500488

INR

28,857.00

30.15 (0.1%)

BSENSE

Dec 05

BSE+NSE Vol: 8.87 k

{
  "main_header": {
    "sid": 919728,
    "name": "Abbott India",
    "stock_name": "Abbott India",
    "full_name": "Abbott India Ltd.",
    "name_url": "stocks-analysis/abbott-india",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "28,857.00",
    "chg": 30.15,
    "chgp": "0.1%",
    "dir": 1,
    "prev_price": "28,826.85",
    "mcapval": "61,517.00 Cr",
    "mcap": "Mid Cap",
    "scripcode": 500488,
    "symbol": "ABBOTINDIA",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE358A01014",
    "curr_date": "Dec 05",
    "curr_time": "",
    "bse_nse_vol": "8.87 k",
    "exc_status": "Active",
    "traded_date": "Dec 05, 2025",
    "traded_date_str": "2025 12 05",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/abbott-india-919728-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Is Abbott India technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-abbott-india-technically-bullish-or-bearish-3743008",
        "imagepath": "",
        "date": "2025-12-03 08:39:54",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Current Technical Landscape</strong></p>\n<p>As of 2 December 2025, Abbott India’s technical trend has shifted from mildly bearish to outright bearish, signalling a deterioration in market sentiment. The stock closed at ₹29,240, down from the previous close of ₹29,818.80, reflecting a short-term weakness. The intraday range on the day saw a high of ₹29,899.85 and a low of ₹29,129.15, indicating some volatility but no decisive upward momentum.</p>\n<p>The 52-week price range remains broad, with a high of ₹35,921.55 and a low of ₹25,260.20, underscoring the stock’s capacity for significant swings. However, the current price is closer to the lower end of this range, which may be a concern for momentum traders.</p>\n<p><strong>Momentum Indicators Paint a Bearish Picture</strong></p>\n<p>Several wide..."
      },
      {
        "title": "Abbott India Sees Shift in Market Assessment Amid Mixed Financial and Technical Signals",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/abbott-india-downgraded-to-sell-amid-technical-weakness-and-valuation-concerns-3743122",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/AbbottIndia_mojoScore_3743122.png",
        "date": "2025-12-03 08:17:16",
        "description": "Abbott India, a prominent player in the Pharmaceuticals & Biotechnology sector, has experienced a notable revision in its market evaluation. This shift reflects a complex interplay of factors spanning quality, valuation, financial trends, and technical indicators, underscoring the nuanced environment investors face when analysing the stock."
      },
      {
        "title": "Abbott India Technical Momentum Shifts Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/abbott-india-faces-bearish-momentum-amid-technical-downgrade-and-market-pressure-3742946",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/AbbottIndia_technicaldot_3742946.png",
        "date": "2025-12-03 08:07:18",
        "description": "Abbott India has experienced a notable shift in its technical momentum, reflecting a complex interplay of bearish and bullish signals across key indicators. The stock’s recent price movement and technical parameters suggest a cautious outlook amid evolving market dynamics within the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "How has been the historical performance of Abbott India?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/how-has-been-the-historical-performance-of-abbott-india-3742238",
        "imagepath": "",
        "date": "2025-12-02 22:58:48",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Revenue and Profit Growth</strong></p>\n<p>Over the seven-year period ending March 2025, Abbott India’s net sales have shown a steady upward trend, increasing from ₹3,678.60 crores in March 2019 to ₹6,409.15 crores in March 2025. This represents a compound annual growth rate (CAGR) of approximately 11.5%, reflecting the company’s ability to expand its market presence and product portfolio effectively.</p>\n<p>The operating profit margin, excluding other income, has improved significantly from 16.44% in March 2019 to 26.44% in March 2025. This margin expansion indicates enhanced operational efficiency and cost management. Correspondingly, the profit after tax (PAT) margin rose from 12.24% to 22.07% over the same period, underscoring strong bottom-line growth.</p>\n<p>Profit after tax surged from..."
      },
      {
        "title": "Abbott India Technical Momentum Shifts Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/abbott-india-technical-momentum-shifts-amid-mixed-indicator-signals-3737521",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/AbbottIndia_technicaldot_3737521.png",
        "date": "2025-12-01 08:04:05",
        "description": "Abbott India has exhibited a nuanced shift in its technical momentum, reflecting a complex interplay of market indicators that suggest a transition from bearish to mildly bearish trends. This development comes amid a backdrop of mixed signals from key technical indicators such as MACD, RSI, Bollinger Bands, and moving averages, warranting a closer examination of the stock’s price dynamics and comparative performance against the broader market."
      },
      {
        "title": "Abbott India Technical Momentum Shifts Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/abbott-india-technical-momentum-shifts-amid-bearish-indicators-3734704",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/AbbottIndia_technicaldot_3734704.png",
        "date": "2025-11-28 08:06:20",
        "description": "Abbott India is currently exhibiting a shift in technical momentum, with recent evaluation adjustments reflecting a transition from mildly bearish to bearish trends. The stock’s price action, combined with key technical indicators such as MACD, RSI, and moving averages, suggests a nuanced market assessment amid broader sector and benchmark comparisons."
      },
      {
        "title": "Abbott India Sees Shift in Market Assessment Amid Mixed Financial and Technical Signals",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/abbott-india-upgraded-to-hold-by-marketsmojo-on-technical-and-valuation-grounds-3727819",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/AbbottIndia_mojoScore_3727819.png",
        "date": "2025-11-25 08:37:41",
        "description": "Abbott India, a key player in the Pharmaceuticals & Biotechnology sector, has experienced a notable revision in its market evaluation, reflecting a nuanced interplay of technical indicators, valuation metrics, financial trends, and quality parameters. This article analyses the factors influencing the recent shift in the company’s assessment, providing investors with a comprehensive understanding of its current standing."
      },
      {
        "title": "Abbott India Technical Momentum Shifts Amid Mixed Indicator Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/abbott-india-technical-momentum-shifts-amid-mixed-indicator-signals-3727600",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/AbbottIndia_technicaldot_3727600.png",
        "date": "2025-11-25 08:12:08",
        "description": "Abbott India has exhibited a nuanced shift in its technical momentum, reflecting a complex interplay of indicator signals across weekly, monthly, and daily timeframes. The stock’s recent price movements and technical parameters suggest a transition from a bearish stance towards a more neutral to mildly bearish outlook, underscoring the importance of closely monitoring momentum indicators such as MACD, RSI, moving averages, and volume-based metrics."
      },
      {
        "title": "Are Abbott India latest results good or bad?",
        "link": "https://www.marketsmojo.com/news/result-analysis/are-abbott-india-latest-results-good-or-bad-3680511",
        "imagepath": "",
        "date": "2025-11-07 19:22:34",
        "description": "Abbott India's latest financial results for Q2 FY26 reflect a company demonstrating strong operational efficiency and profitability, with net sales reaching ₹1,757.15 crores, indicating a year-on-year growth of 7.62%. This performance showcases the company's ability to navigate a competitive landscape effectively. The net profit for the quarter was ₹415.27 crores, marking a year-on-year increase of 15.81%, which underscores the company's solid bottom-line growth.\n\nThe operating margin expanded to 28.58%, the highest level recorded in the past eight quarters, driven by improved cost management and a favorable product mix. Additionally, the return on equity stood at an impressive 34.31%, highlighting Abbott India's exceptional capital efficiency.\n\nDespite these positive operational metrics, the company has faced challenges in the stock market, with a notable decline of 9.62% in share price over the past three..."
      }
    ],
    "total": 186,
    "sid": "919728",
    "stock_news_url": "https://www.marketsmojo.com/news/abbott-india-919728"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Change in Management",
      "datetime": "25-Nov-2025",
      "details": "Change in Senior Management Personnel.",
      "source": "BSE"
    },
    {
      "caption": "Approval Of Central Government For Appointment Of Managing Director",
      "datetime": "24-Nov-2025",
      "details": "Approval of Central Government for appointment of Managing Director",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "07-Nov-2025",
      "details": "Newspaper Advertisement",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Abbott India Ltd. has declared <strong>4750%</strong> dividend, ex-date: 25 Jul 25",
          "dt": "2025-07-25",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Is Abbott India technically bullish or bearish?

2025-12-03 08:39:54

Current Technical Landscape

As of 2 December 2025, Abbott India’s technical trend has shifted from mildly bearish to outright bearish, signalling a deterioration in market sentiment. The stock closed at ₹29,240, down from the previous close of ₹29,818.80, reflecting a short-term weakness. The intraday range on the day saw a high of ₹29,899.85 and a low of ₹29,129.15, indicating some volatility but no decisive upward momentum.

The 52-week price range remains broad, with a high of ₹35,921.55 and a low of ₹25,260.20, underscoring the stock’s capacity for significant swings. However, the current price is closer to the lower end of this range, which may be a concern for momentum traders.

Momentum Indicators Paint a Bearish Picture

Several wide...

Abbott India Sees Shift in Market Assessment Amid Mixed Financial and Technical Signals

2025-12-03 08:17:16

Abbott India, a prominent player in the Pharmaceuticals & Biotechnology sector, has experienced a notable revision in its market evaluation. This shift reflects a complex interplay of factors spanning quality, valuation, financial trends, and technical indicators, underscoring the nuanced environment investors face when analysing the stock.

Abbott India Technical Momentum Shifts Amid Mixed Market Signals

2025-12-03 08:07:18

Abbott India has experienced a notable shift in its technical momentum, reflecting a complex interplay of bearish and bullish signals across key indicators. The stock’s recent price movement and technical parameters suggest a cautious outlook amid evolving market dynamics within the Pharmaceuticals & Biotechnology sector.

How has been the historical performance of Abbott India?

2025-12-02 22:58:48

Revenue and Profit Growth

Over the seven-year period ending March 2025, Abbott India’s net sales have shown a steady upward trend, increasing from ₹3,678.60 crores in March 2019 to ₹6,409.15 crores in March 2025. This represents a compound annual growth rate (CAGR) of approximately 11.5%, reflecting the company’s ability to expand its market presence and product portfolio effectively.

The operating profit margin, excluding other income, has improved significantly from 16.44% in March 2019 to 26.44% in March 2025. This margin expansion indicates enhanced operational efficiency and cost management. Correspondingly, the profit after tax (PAT) margin rose from 12.24% to 22.07% over the same period, underscoring strong bottom-line growth.

Profit after tax surged from...

Abbott India Technical Momentum Shifts Amid Mixed Market Signals

2025-12-01 08:04:05

Abbott India has exhibited a nuanced shift in its technical momentum, reflecting a complex interplay of market indicators that suggest a transition from bearish to mildly bearish trends. This development comes amid a backdrop of mixed signals from key technical indicators such as MACD, RSI, Bollinger Bands, and moving averages, warranting a closer examination of the stock’s price dynamics and comparative performance against the broader market.

Abbott India Technical Momentum Shifts Amid Mixed Market Signals

2025-11-28 08:06:20

Abbott India is currently exhibiting a shift in technical momentum, with recent evaluation adjustments reflecting a transition from mildly bearish to bearish trends. The stock’s price action, combined with key technical indicators such as MACD, RSI, and moving averages, suggests a nuanced market assessment amid broader sector and benchmark comparisons.

Abbott India Sees Shift in Market Assessment Amid Mixed Financial and Technical Signals

2025-11-25 08:37:41

Abbott India, a key player in the Pharmaceuticals & Biotechnology sector, has experienced a notable revision in its market evaluation, reflecting a nuanced interplay of technical indicators, valuation metrics, financial trends, and quality parameters. This article analyses the factors influencing the recent shift in the company’s assessment, providing investors with a comprehensive understanding of its current standing.

Abbott India Technical Momentum Shifts Amid Mixed Indicator Signals

2025-11-25 08:12:08

Abbott India has exhibited a nuanced shift in its technical momentum, reflecting a complex interplay of indicator signals across weekly, monthly, and daily timeframes. The stock’s recent price movements and technical parameters suggest a transition from a bearish stance towards a more neutral to mildly bearish outlook, underscoring the importance of closely monitoring momentum indicators such as MACD, RSI, moving averages, and volume-based metrics.

Are Abbott India latest results good or bad?

2025-11-07 19:22:34

Abbott India's latest financial results for Q2 FY26 reflect a company demonstrating strong operational efficiency and profitability, with net sales reaching ₹1,757.15 crores, indicating a year-on-year growth of 7.62%. This performance showcases the company's ability to navigate a competitive landscape effectively. The net profit for the quarter was ₹415.27 crores, marking a year-on-year increase of 15.81%, which underscores the company's solid bottom-line growth. The operating margin expanded to 28.58%, the highest level recorded in the past eight quarters, driven by improved cost management and a favorable product mix. Additionally, the return on equity stood at an impressive 34.31%, highlighting Abbott India's exceptional capital efficiency. Despite these positive operational metrics, the company has faced challenges in the stock market, with a notable decline of 9.62% in share price over the past three...

View All News